Equity Overview
Price & Market Data
Price: $0.232
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $21,387,820
Volume: 0
Performance Metrics
1 Week: 10.31%
1 Month: 25.49%
3 Months: 34.69%
6 Months: 54.44%
1 Year: 36.27%
YTD: 98.00%
Details
Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic platform to detect, monitor, and treat cancer. The company invests in and develops liquid biopsy metabolic panel assay for early stage diagnosis of lung cancer. It has a strategic partnership with Rubix LS to develop diagnostic tools to enhance lung cancer screening and improve breast cancer screening program for women with dense breasts. The company was incorporated in 2014 and is headquartered in Richmond, Canada.